Commitment COM-382
Post-approval commitment for EMA-2023-0082. Category: Risk Management. Priority: high.
Commitment ID
COM-382
Application
Authority
European Medicines Agency
Category
Risk Management
Priority
high
Status
Blocked
Due Date
2025-02-15
Completed At
—
Owner
Aisha Okonkwo
Created
2023-04-14
Description
Complete Phase IV post-marketing observational study (n=500)
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.